Biomarker Technologies unveils SLAF-seq for genetic variation studies

Biomarker Technologies has introduced SLAF-seq (Specific-Locus Amplified Fragment Sequencing), a method designed to facilitate the study of genetic variation across diverse populations. This advanced genome sequencing technique allows for the identification of genetic markers throughout the genome without the absolute necessity of a reference genome.

The SLAF-seq method involves generating genomic tags that are evenly distributed across the genome and can be sequenced using an Illumina platform. The company describes the technique as flexible, which can be particularly beneficial for population studies involving a large number of samples and for species with large genomes.

The process begins with an "in silico" pre-design phase to analyze the genome and identify suitable restriction enzymes. This step aims to ensure even distribution and allows for experimental optimization using three different enzyme combinations. SLAF-seq differs from some similar techniques, such as ddRAD-seq, in its choice of restriction enzymes and library construction strategy.

The company highlights the technique's applicability for constructing genetic maps, conducting genome-wide association studies (GWAS), and exploring population evolution. SLAF-seq is presented as a practical approach for large-scale genetic studies requiring efficient marker discovery across many individuals.